5:35 PM
Dec 07, 2012
 |  BC Extra  |  Company News

MD Anderson licenses OX40 antibodies to GSK

The University of Texas MD Anderson Cancer Center (Houston, Texas) granted GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) exclusive, worldwide rights to develop and commercialize...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >